ArticleJournal for immunotherapy of cancer2022

Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC.

Milou Schuurbiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.